USFDA conducts audit at Indoco Remedies’ sterile facility in Goa

06 Jun 2019 Evaluate

US Food and Drug Administration (USFDA) has conducted audit at Indoco Remedies’ sterile manufacturing facility in Verna, Goa (Plant II) from May 27, 2019 to June 04, 2019, issuing 4 observations (483s). These observations are procedural in nature, not pertaining to data integrity.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

192.50 3.50 (1.85%)
20-Mar-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.40
Dr. Reddys Lab 1294.50
Cipla 1256.00
Zydus Lifesciences 889.70
Lupin 2318.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×